Health Consequences of Fear of Cancer Recurrence in Breast Cancer Survivors and Partners
乳腺癌幸存者和伴侣担心癌症复发的健康后果
基本信息
- 批准号:10378516
- 负责人:
- 金额:$ 63.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdjuvantAdjuvant TherapyBiological MarkersBody CompositionBreast Cancer survivorCancer EtiologyCancer SurvivorCardiovascular DiseasesCross-Sectional StudiesDataDevelopmentDiagnosisEquationFastingFrightFundingGlycosylated hemoglobin AGoalsHealthHealth behaviorHealth behavior and outcomesHormonalIndividualInsulin ResistanceInvestigationKnowledgeLinkLipidsLiteratureMalignant NeoplasmsMeasuresMetabolic DiseasesMethodsModelingMonitorMorbidity - disease rateOutcomeParameter EstimationPatient Self-ReportPatientsPersonal SatisfactionPersonsPhysical activityPopulationPrevalencePsyche structurePublic HealthPublishingQuality of lifeRecommendationRecurrenceRecurrent Malignant NeoplasmReportingResearchRiskSleepSleep disturbancesSpousesStrenuous ExerciseTimeTreatment/Psychosocial EffectsWeight GainWomanWorkcancer diagnosiscancer recurrencecancer therapycardiometabolismdiariesimprovedindexinginnovationintervention refinementmalignant breast neoplasmmedication compliancemortalitypower analysisscreeningsedentary lifestylesleep qualitysleep quantitysymptom managementsymptomatic improvementtreatment adherence
项目摘要
Project Summary/Abstract
Breast cancer (BC) is the most commonly diagnosed cancer and the second leading cause of
cancer mortality among women in the US (ACS, 2017). High baseline prevalence, increasing
screening rates, and better treatments have all contributed to a large population of BC survivors
that will increase from an estimated 3.5 million in 2016 to a projected 4.5 million in the next 10
years (ACS, 2017). Multiple studies document fear of cancer recurrence (FCR) as a top long-
term concern of both cancer survivors and their significant others that impacts on quality of life.
Despite an increasing emphasis on FCR in the literature, a critical gap in knowledge is how FCR
can produce health behavior consequences with known implications for long-term health
outcomes. The overall objective of this proposal is to examine medication adherence, physical
activity/sedentary behavior, and sleep as three proximal health behavior outcomes that are
modifiable and have been linked to recurrence (for patients) as well as morbidity and mortality
(for both patients and spouses/partners). Moreover, FCR and health behaviors are concordant
within-couple reflecting an interdependent and interpersonal context that, if ignored, would limit
a complete understanding of important health consequences of FCR. Preliminary data from a
recently completed NCI-funded R21 project form the scientific premise and the basis of power
analyses for the specific and exploratory aims. Using longitudinal, within-person methods as
well as individual and dyadic multilevel structural equation modeling, we will pursue the
following hypothesis-driven aims: 1) identify the consequences of FCR for physical activity; 2)
identify the consequences of FCR for adherence to adjuvant hormonal treatment; and 3) identify
the consequences of FCR for sleep quantity and quality. Finally, using biomarkers of cardio-
metabolic health risk (i.e., HbA1c, lipids, insulin resistance, body composition), we will explore
the links between the targeted health behaviors and these health outcomes. A long-term
objective of the proposed work is to influence the development and refinement of interventions
for FCR and health behaviors ultimately increasing optimal mental and physical well-being of
cancer survivors and their spouses/partners.
项目摘要/摘要
乳腺癌(BC)是最常见的诊断癌症,也是癌症的第二大病因。
美国女性癌症死亡率(美国癌症协会,2017年)。高基线流行率,不断增加
筛查率和更好的治疗都为不列颠哥伦比亚省的大量幸存者做出了贡献
这将从2016年的估计350万人增加到未来10年的450万人
年(美国计算机协会,2017)。多项研究表明,对癌症复发的恐惧(FCR)是一种长期的
癌症幸存者和他们的另一半对生活质量的长期关注。
尽管在文献中越来越强调FCR,但在知识方面的一个关键差距是FCR如何
会产生健康行为后果,并对长期健康产生已知的影响
结果。这项建议的总体目标是检查服药依从性、体格检查
活动/久坐行为和睡眠作为三种近端健康行为结果,分别是
可修改,并与(患者)复发以及发病率和死亡率有关
(适用于患者和配偶/伴侣)。此外,FCR和健康行为是一致的
内部-反映相互依赖和人际关系的背景,如果忽略,将限制
对FCR的重要健康后果有全面的了解。来自美国的初步数据
新近完成的NCI资助的R21项目形成了科学的前提和动力的基础
具体目标和探索性目标的分析。使用纵向的、面对面的方法
以及个体和并元多层结构方程建模,我们将追求
以下是假设驱动的目标:1)确定FCR对身体活动的影响;2)
确定FCR对坚持激素辅助治疗的后果;以及3)确定
FCR对睡眠数量和质量的影响。最后,使用有氧生物标记物-
代谢健康风险(即HbA1c、血脂、胰岛素抵抗、身体成分),我们将探讨
有针对性的健康行为和这些健康结果之间的联系。一个长期的
拟议工作的目标是影响干预措施的发展和完善
对于FCR和健康行为最终增加最佳的身心健康
癌症幸存者及其配偶/伴侣。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jean-Philippe Laurenceau其他文献
Jean-Philippe Laurenceau的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Jean-Philippe Laurenceau', 18)}}的其他基金
Health Consequences of Fear of Cancer Recurrence in Breast Cancer Survivors and Partners
乳腺癌幸存者和伴侣担心癌症复发的健康后果
- 批准号:
9974152 - 财政年份:2020
- 资助金额:
$ 63.03万 - 项目类别:
Intensive Longitudinal Study of Fear of Recurrence in Cancer Patients and Spouses
癌症患者及其配偶对复发的恐惧的深入纵向研究
- 批准号:
8533703 - 财政年份:2013
- 资助金额:
$ 63.03万 - 项目类别:
Intensive Longitudinal Study of Fear of Recurrence in Cancer Patients and Spouses
癌症患者及其配偶对复发的恐惧的深入纵向研究
- 批准号:
8637942 - 财政年份:2013
- 资助金额:
$ 63.03万 - 项目类别:
INTIMACY PROCESSES IN MARRIAGE--A DAILY DIARY APPROACH
婚姻中的亲密过程——每日日记法
- 批准号:
2523201 - 财政年份:1998
- 资助金额:
$ 63.03万 - 项目类别:
相似海外基金
Countering sympathetic vasoconstriction during skeletal muscle exercise as an adjuvant therapy for DMD
骨骼肌运动期间对抗交感血管收缩作为 DMD 的辅助治疗
- 批准号:
10735090 - 财政年份:2023
- 资助金额:
$ 63.03万 - 项目类别:
The ESCAPE clinical trial of circulating tumor DNA to guide adjuvant therapy in chemo-resistant triple negative breast cancer
循环肿瘤 DNA 指导化疗耐药三阴性乳腺癌辅助治疗的 ESCAPE 临床试验
- 批准号:
494901 - 财政年份:2023
- 资助金额:
$ 63.03万 - 项目类别:
Operating Grants
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck Cancer
一项 I 型混合有效性实施试验,用于评估基于导航的多级干预措施,以减少头颈癌患者开始辅助治疗的延迟
- 批准号:
10714537 - 财政年份:2023
- 资助金额:
$ 63.03万 - 项目类别:
Multi-modal machine learning to guide adjuvant therapy in surgically resectable colorectal cancer
多模式机器学习指导可手术切除结直肠癌的辅助治疗
- 批准号:
10588103 - 财政年份:2023
- 资助金额:
$ 63.03万 - 项目类别:
Efficacy of ethanol adjuvant therapy after resection of malignant soft tissue tumors
恶性软组织肿瘤切除术后乙醇辅助治疗的疗效
- 批准号:
22K09407 - 财政年份:2022
- 资助金额:
$ 63.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of immune response cells and development of novel adjuvant therapy for sublingual immunotherapy
免疫应答细胞的鉴定和舌下免疫治疗新型辅助疗法的开发
- 批准号:
21KK0287 - 财政年份:2022
- 资助金额:
$ 63.03万 - 项目类别:
Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
Pursuing molecular biomarkers to guide adjuvant therapy for HPV+ head and neck cancers after transoral robotic surgery
寻找分子生物标志物来指导经口机器人手术后 HPV 头颈癌的辅助治疗
- 批准号:
10357120 - 财政年份:2022
- 资助金额:
$ 63.03万 - 项目类别:
Biomarker research using two prospective studies on preoperative and postoperative adjuvant therapy for pancreatic cancer
使用两项关于胰腺癌术前和术后辅助治疗的前瞻性研究进行生物标志物研究
- 批准号:
21K08700 - 财政年份:2021
- 资助金额:
$ 63.03万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Personalized Resistant Starch as an Adjuvant Therapy for Pediatric Inflammatory Bowel Disease
个性化抗性淀粉作为小儿炎症性肠病的辅助治疗
- 批准号:
437315 - 财政年份:2020
- 资助金额:
$ 63.03万 - 项目类别:
Studentship Programs
Tailored adjuvant therapy in POLE-mutated and p53-wildtype early stage endometrial cancer (TAPER)
POLE 突变和 p53 野生型早期子宫内膜癌 (TAPER) 的定制辅助治疗
- 批准号:
435603 - 财政年份:2020
- 资助金额:
$ 63.03万 - 项目类别:
Operating Grants